1 – 1 of 1
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progression
Ho, Victor ; Lim, Tong Seng ; Lee, Justin ; Steinberg, Jeffrey ; Szmyd, Radoslaw ; Tham, Muly ; Yaligar, Jadegoud ; Kaldis, Philipp LU
; Abastado, Jean Pierre
and Chew, Valerie
(2015)
In Oncotarget
6(29).
p.27252-27266
- Contribution to journal › Article